An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

Autor: Liu Xiaolin, Nanshan Zhong, Jia Wu, Fan Zhang, Xuefeng Niu, Chufang Li, Yichu Liu, Jia Luo, Xinglong Liu, Ying Feng, Jincun Zhao, Peiyu Hu, Chenchen Yang, Guan Suhua, Ren-Di Jiang, Xinwen Chen, Ling Chen, Zhiming Yuan, Xuehua Zheng, Qian Wang, Yingying Gu, Chao Shan, Liqiang Feng, Yiwu Zhou, Jing Sun, Yongcun Xu, Changwen Ke, Tao Xu, Weiqi Pan, Bo Liu, Pingchao Li
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Serotype
Male
Live attenuated vaccines
viruses
Respiratory System
General Physics and Astronomy
02 engineering and technology
medicine.disease_cause
Antibodies
Viral

Mice
Medicine
skin and connective tissue diseases
lcsh:Science
Coronavirus
Immunity
Cellular

Mice
Inbred BALB C

Vaccines
Synthetic

Multidisciplinary
biology
021001 nanoscience & nanotechnology
Vaccination
Experimental models of disease
Spike Glycoprotein
Coronavirus

Female
Antibody
0210 nano-technology
Coronavirus Infections
COVID-19 Vaccines
Science
Pneumonia
Viral

Dose-Response Relationship
Immunologic

Article
General Biochemistry
Genetics and Molecular Biology

Adenoviridae
03 medical and health sciences
Betacoronavirus
Immune system
Immunity
Animals
Humans
Pandemics
business.industry
SARS-CoV-2
fungi
COVID-19
Viral Vaccines
General Chemistry
biochemical phenomena
metabolism
and nutrition

Virology
Antibodies
Neutralizing

Macaca mulatta
body regions
030104 developmental biology
HEK293 Cells
Viral infection
biology.protein
Nasal administration
lcsh:Q
business
Zdroj: Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Nature Communications
ISSN: 2041-1723
Popis: The rapid spread of coronavirus SARS-CoV-2 greatly threatens global public health but no prophylactic vaccine is available. Here, we report the generation of a replication-incompetent recombinant serotype 5 adenovirus, Ad5-S-nb2, carrying a codon-optimized gene encoding Spike protein (S). In mice and rhesus macaques, intramuscular injection with Ad5-S-nb2 elicits systemic S-specific antibody and cell-mediated immune (CMI) responses. Intranasal inoculation elicits both systemic and pulmonary antibody responses but weaker CMI response. At 30 days after a single vaccination with Ad5-S-nb2 either intramuscularly or intranasally, macaques are protected against SARS-CoV-2 challenge. A subsequent challenge reveals that macaques vaccinated with a 10-fold lower vaccine dosage (1 × 1010 viral particles) are also protected, demonstrating the effectiveness of Ad5-S-nb2 and the possibility of offering more vaccine dosages within a shorter timeframe. Thus, Ad5-S-nb2 is a promising candidate vaccine and warrants further clinical evaluation.
A vaccine protecting from SARS-CoV-2 infection is needed. Here the authors generate a replication-incompetent adenovirus based vaccine expressing SARS-CoV-2 spike, show protection from infection in non-human primates, and analyze the immune response after intramuscular and intranasal vaccination.
Databáze: OpenAIRE